Nav: Home

Wilderness Medical Society issues important new clinical practice guidelines

February 05, 2020

Philadelphia, February 5, 2020 - The Wilderness Medical Society (WMS) has released new clinical practice guidelines in a supplement to Wilderness & Environmental Medicine, published by Elsevier. This issue features updates to previously published clinical practice guidelines and newly developed guidelines on diabetes management and spinal immobilization in the wilderness setting.

These revised and new WMS clinical practice guidelines have been developed and guest-edited by Christopher Davis, MD, Department of Emergency Medicine-Wilderness and Environmental Medicine, University of Colorado School of Medicine, Aurora, CO, USA; Michael Caudell, MD, Department of Emergency Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA; and Tracy Cushing, MD, MPH, Department of Emergency Medicine, University of Colorado Hospital, Aurora, CO, USA. All recommendations are graded based upon the clinical strength of available evidence as outlined by the American College of Chest Physicians (ACCP).

"Clinical practice guidelines are increasingly necessary to help clinicians navigate and synthesize the expanding volume of available medical literature," explained Dr. Davis. "Our guidelines are continuously updated to reflect the most current literature and recommendations for wilderness medicine pathology and are uniquely interdisciplinary in their authorship. Our goal is to provide the most up-to-date and relevant clinical information to frontline providers in wilderness or austere environments."

"The WMS is committed to ensuring that each clinical practice guideline is developed by a working group representative of the best experts in the field and multidisciplinary in scope," added Dr. Davis. "As an interdisciplinary author group, the impact of these guidelines is far reaching both in terms of scope of practitioners and in breadth of information. These address unique pathology such as altitude illness that are not covered in other medical literature and sometimes provide the ONLY clinical practice guidelines for particular illnesses."

New clinical practice guidelines include:

Clinical practice guidelines for diabetes management

Athletes with both type 1 and type 2 diabetes are undertaking ever-expanding wilderness challenges. At least three individuals with diabetes have successfully reached the summit of Mount Everest. In a recent survey, people who self-identified as having diabetes represented seven percent of 3,000 surveyed ultramarathon runners. Both high and low blood sugar can be catastrophic in environments where there are limited resources, and glycemic control is more challenging in extreme conditions, needing additional monitoring, treatment adjustments, and careful planning beforehand.

The authors of a new guideline on diabetes management point out that there are so many variables that it is impossible to come up with a single set of guidelines. They recommend personalizing the medical care of each individual based on personal history and input, and advise adjusting insulin doses and diet plans according to the type and degree of activity that will be performed; an individual's baseline level of fitness; the individual's athletic and disease history; and the environment to which the athlete will be exposed. They also recommend that athletes with diabetes should carry a basic written plan developed with their endocrinologist describing their usual treatment regimen; a plan for basic adjustments in the back country; basics of hypo-/hyperglycemia management; and an emergency action plan.

Clinical practice guidelines for spinal cord protection

The low volume and quality of scientific evidence available does not support the current rationale for immobilizing a potential spine injury in the wilderness environment, according to the updated guideline on spinal injury care, suggesting that historic principles of out-of-hospital spinal injury care may have been more influenced by medicolegal implications and untested theory than by clinical or scientific evidence. The focus of this current guideline is to present an evidence-based approach to out-of-hospital care of an existing or potential spinal cord injury in wilderness environments that minimizes the possibility of neurologic deterioration or making the injury worse from the time of extrication to arrival at a medical facility. Current evidence suggests that rigid immobilization via collar or backboard can result in a worse patient outcome in both blunt and penetrating trauma. Instead, the guidelines propose that spinal motion restriction (SMR) may be the most appropriate mechanism currently available.

Other updated guidelines cover the prevention and treatment of acute altitude illness; prevention and treatment of frostbite; prevention and treatment of heat illness; prevention and treatment of drowning; water disinfection for wilderness, international travel, and austere conditions; and out-of-hospital evaluation and treatment of accidental hypothermia. They also highlight several important questions that remain to be addressed and could serve as a focus for future research, such as, the role of acetazolamide in preventing and treating high altitude cerebral edema; determining the optimal rate of ascent to prevent altitude illness; the role of staged ascent, preacclimatization, and hypoxic tents in altitude illness prevention; optimal methods of resuscitating hypothermic patients in cardiac arrest; and the use of technological innovations to allow access to wilderness pursuits such as big wall rock climbing and scuba diving that have historically been off limits to those with diabetes.

Dr. Cushing added a note of caution about the challenges faced in developing guidelines for illnesses encountered in the wilderness. "Wilderness recreation is increasingly popular. Accordingly, more individuals are at risk today than ever before. However, it is challenging to design and execute randomized clinical trials, as the illnesses we treat are not only rare, they also occur in challenging and remote environments."

"Previously published guidelines have been some of the most highly-cited articles in Wilderness & Environmental Medicine. It is our foremost goal to continue the tradition of bringing forward the best available data to the wilderness medical provider," concluded the guest editors.


Related Diabetes Articles:

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at